Skip to content
10-K

Annual Report

ANTIVIRAL TECHNOLOGIES, INC.

0001137050-14-000058

← back to feed
Filed
Mar 28, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Dec 31, 2013 150M sh
Operating Cash Flow FY 2013 · Dec 31, 2013 −$87.52K
Operating Cash Flow FY 2013 · Dec 31, 2013 −$1.29M
Operating Cash Flow FY 2013 · Dec 31, 2012 −$139.18K
Cash And Equivalents FY 2013 · Dec 31, 2013 $499
Cash And Equivalents FY 2013 · Dec 31, 2012 $699
Cash And Equivalents FY 2013 · Dec 31, 2011 $3.94K
Stockholders Equity FY 2013 · Dec 31, 2013 −$2.68M
Stockholders Equity FY 2013 · Dec 31, 2012 −$2.3M
Total Liabilities FY 2013 · Dec 31, 2013 $3.17M
Total Liabilities FY 2013 · Dec 31, 2012 $2.79M
Current Assets FY 2013 · Dec 31, 2013 $501
Current Assets FY 2013 · Dec 31, 2012 $701
Total Assets FY 2013 · Dec 31, 2013 $484.16K
Total Assets FY 2013 · Dec 31, 2012 $485.2K
Sga Expense FY 2013 · Dec 31, 2013 $375.25K
Sga Expense FY 2013 · Dec 31, 2013 $2.5M
Sga Expense FY 2013 · Dec 31, 2012 $356.44K
Net Income FY 2013 · Dec 31, 2013 −$375.95K
Net Income FY 2013 · Dec 31, 2013 −$2.68M
Net Income FY 2013 · Dec 31, 2012 −$363.28K